SCHEMBL5082145

SCHEMBL5082145

COCCOC1CC(c2nc(-c3cc4nc(-c5ccccc5)ccc4cc3Cl)c3cnccn23)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 14/20 0.39
CYP3A4 P08684 9/20 0.39
INSR P06213 2/20 0.39
KDR P35968 2/20 0.39
EGFR P00533 1/20 0.39
MAPK3 P27361 2/20 0.37
MAPK1 P28482 2/20 0.37
MAPK6 Q16659 1/20 0.37
BTK Q06187 5/20 0.36
RIPK2 O43353 1/20 0.36
ROCK2 O75116 1/20 0.36
LATS1 O95835 1/20 0.36
LCK P06239 1/20 0.36
LYN P07948 1/20 0.36
RET P07949 1/20 0.36
ABCB1 P08183 1/20 0.36
MET P08581 1/20 0.36
FGFR1 P11362 1/20 0.36
INSRR P14616 1/20 0.36
FECH P22830 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL401324 0.85 IGF1R (0.56) IGF1RCYP3A4INSRKDREGFR
SCHEMBL5138539 0.82 IGF1R (0.58) IGF1RCYP3A4INSRKDREGFR
SCHEMBL5083975 0.80 IGF1R (0.43) IGF1RCYP3A4INSRKDREGFR
SCHEMBL400937 0.74 IGF1R (0.71) IGF1RCYP3A4INSRKDREGFR
SCHEMBL3908990 0.73 IGF1R (0.51) IGF1RCYP3A4INSRKDREGFR
SCHEMBL19264006 0.72 IGF1R (0.54) IGF1RCYP3A4INSRKDREGFR
SCHEMBL5137559 0.72 IGF1R (0.45) IGF1RCYP3A4INSRKDREGFR
SCHEMBL19264009 0.71 IGF1R (0.53) IGF1RCYP3A4INSRKDREGFR
SCHEMBL5138538 0.71 IGF1R (0.40) IGF1RCYP3A4INSRKDREGFR
SCHEMBL1683109 0.71 IGF1R (0.71) IGF1RCYP3A4INSRKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed